Health Highlights, April 7, 2022

Is the CDC in crisis? Former agency heads debate its future. A handful of former directors say they support a sweeping review of the agency that's been ordered up by current director Dr. Rochelle Walensky. Read more
Experimental pill may fight antibiotic-resistant UTIs. The new pill, called tebipenem HBr, worked as well as a standard IV antibiotic in treating patients hospitalized with "complicated" UTIs, a study has found. Read more
Upped risk for clots lasts at least 6 months after COVID. A new study suggests that COVID-19 is an independent risk factor for deep vein thrombosis, pulmonary embolism and bleeding, researchers say. Read more
U.S. nursing home industry needs an overhaul. A major new report finds facilities awash in ineffective care and staffing shortages. Its authors call for sweeping changes in an industry whose failures have only been exacerbated by the pandemic. Read more
Are retooled COVID booster shots coming this fall? Federal health officials told an expert advisory panel on Wednesday that clinical trials of potential candidates would have to begin by next month, and a final formula chosen by June. Read more
Related Posts
New York Reports 5 Omicron Cases, U.S. Total Rises to 9
FRIDAY, Dec. 3, 2021 (HealthDay News) -- Five cases of the Omicron coronavirus...
New Drug Helps Tame Uncontrolled High Blood Pressure
TUESDAY, Nov. 8, 2022 (HealthDay News) – Some patients with high blood pressure...
Las pruebas constantes de cáncer de mama bajan el riesgo de morir de la enfermedad en un 72 por ciento
LUNES, 5 de junio de 2023 (HealthDay News) -- Las mamografías de detección...
Methotrexate Linked to Increased Risk for Skin Cancer
WEDNESDAY, Feb. 22, 2023 (HealthDay News) -- Methotrexate is associated with an...
